首页|血管内超声检测对缺血伴非阻塞性冠状动脉疾病患者用药及预后的影响

血管内超声检测对缺血伴非阻塞性冠状动脉疾病患者用药及预后的影响

扫码查看
目的 分析血管内超声(IVUS)对缺血伴非阻塞性冠状动脉疾病(INOCA)患者用药及预后的影响.方法 选择2019年8月至2021年7月上海市普陀区利群医院心内科收治的INOCA患者160例,根据有无行IVUS检查将患者分为观察组和对照组各80例,观察组按IVUS检查结果再分为重度狭窄亚组(斑块负荷≥30%)和轻度狭窄亚组(斑块负荷<30%).两组患者均行冠状动脉造影(CAG)检查,随访1年.记录两组患者影像学检查、用药情况和1年内发生主要不良心血管事件(MACE)的情况,计算两组患者用药总分.采用线性回归模型分析有无行IVUS检查对两组患者用药总分的影响.比较两组患者1年内发生MACE的情况,采用Cox回归模型,分析两组患者1年内发生MACE的影响因素.结果 观察组IVUS发现CAG无法发现的不稳定斑块38例(47.5%),发现CAG未发现的肌桥5例(6.3%).两组患者CAG检查的冠状动脉狭窄程度、CAG发现的肌桥占比、明确诊断的肌桥占比比较,差异均无统计学意义(均P>0.05).观察组血管紧张素转化酶抑制剂、血管紧张素受体拮抗剂、β受体阻滞剂的使用率高于对照组,差异均有统计学意义(均P<0.05).重度狭窄亚组他汀类药物的使用率高于轻度狭窄亚组,钙通道阻滞剂的使用率低于轻度狭窄亚组,差异均有统计学意义(均P<0.05).两亚组其他药物的使用率比较,差异均无统计学意义(均P>0.05).回归分析显示行IVUS检查是两组患者用药总分的影响因素(P<0.05).随访1年内,观察组发生MACE 3例(3.8%),对照组发生MACE 10例(12.5%),差异有统计学意义(P=0.043).Cox回归模型显示行IVUS检查和CAG评级是两组患者1年内发生MACE的影响因素(P<0.05).结论 行IVUS检查能够指导INOCA患者用药,改善预后,值得推广.
Clinical study on the effect of intravascular ultrasound on medication and prognosis of patients with ischemia and non-obstruc-tive coronary artery disease
Objective To analyze the effect of intravascular ultrasound(IVUS)on medication and prognosis of patients with ischemia and non-obstructive coronary artery disease(INOCA).Methods A total of 160 patients with INOCA were selected,who were admitted to the Department of Cardiology of Shanghai Putuo District Liqun Hospital from August 2019 to July 2021.The patients were divided into observation group and control group,with 80 cases in each group,according to whether IVUS examination was performed.And the observation group was further divided into severe stenosis subgroup(plaque burden ≥30%)and mild stenosis subgroup(plaque burden<30%)according to the IVUS examination results.Coronary angiography(CAG)was performed in both groups and they were followed up for one year.The imaging examinations,medication and major adverse cardiovascular events(MACE)within one year of the two groups were recorded,and the total drug scores of the two groups were calculated.Regression analysis of the total drug scores and the presence or absence of IVUS examination was performed in the two groups.The occurrence of MACE within one year was compared between the two groups,and Cox risk analysis was performed to analyze the influencing factors of MACE within one year in the two groups.Results In the observation group,38 cases(47.5%)were found to have unstable plaques that could not be found by CAG,and 5 cases(6.3%)were found to have myocardial bridges that were not found by CAG.There were no significant differences between the two groups in the degree of coronary artery stenosis,the proportion of myocardial bridges found by CAG,and the proportion of confirmed myocardial bridges(all P>0.05).The use rates of angiotension converting enzyme inhibitors(ACEI),angiotensin receptor antagonists(ARB)and β-blockers in the observation group were higher than those of the control group,and the differences were statistically significant(all P<0.05).The use rate of statins in the severe stenosis subgroup was higher than that in the mild stenosis subgroup,while that of calcium channel blockers was lower compared with the mild stenosis subgroup,and the differences were statistically significant(all P<0.05).There were no significant differences in the use rates of other drugs between the two subgroups(all P>0.05).Regression analysis showed that IVUS examination was the influencing factor for the total drug scores in the two groups(P<0.05).Within one year of follow-up,3 cases(3.8%)of MACE occurred in the observation group and 10 cases(12.5%)in the control group,the difference of which was statistically significant(P=0.043).Cox risk analysis showed that IVUS examination and CAG grade were the influencing factors for the occurrence of MACE within one year in the two groups(P<0.05).Conclusion IVUS examination can guide the medication and improve the prognosis of INOCA patients,which is worthy of promotion.

Intravascular ultrasoundNon-obstructiveCoronary artery diseaseMedicationPrognosis

吴彦、胡燕华、边长勇

展开 >

200333 上海市普陀区利群医院心内科

血管内超声 非阻塞性 冠状动脉疾病 用药 预后

上海市普陀区卫生健康系统科技创新项目

ptkwws202014

2024

浙江医学
浙江省医学会

浙江医学

CSTPCD
影响因子:0.428
ISSN:1006-2785
年,卷(期):2024.46(6)
  • 18